Neurocrine (0K6R) Stock Statistics & Valuation Metrics
Total Valuation
Neurocrine has a market cap or net worth of $14.85B. The enterprise value is $17.57B.
- Market Cap
- $14.85B
- Enterprise Value
- $17.57B
Share Statistics
Neurocrine has 101,649,180 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 101,649,180
- Owned by Insiders
- 1.14%
- Owned by Institutions
- 61.81%
Financial Efficiency
Neurocrine’s return on equity (ROE) is 0.15 and return on invested capital (ROIC) is 10.80%.
- Return on Equity (ROE)
- 0.15
- Return on Assets (ROA)
- 0.10
- Return on Invested Capital (ROIC)
- 10.80%
- Return on Capital Employed (ROCE)
- 0.16
- Revenue Per Employee
- 1.14M
- Profits Per Employee
- 191.44K
- Employee Count
- 2,500
- Asset Turnover
- 0.62
- Inventory Turnover
- 0.76
Valuation Ratios
The current PE Ratio of Neurocrine is 20.72. Neurocrine’s PEG ratio is 0.20.
- PE Ratio
- 20.72
- PS Ratio
- 4.40
- PB Ratio
- 4.00
- Price to FCF
- 17.06
- Price to Operating Cash Flow
- 16.43
- PEG Ratio
- 0.20
Income Statement
In the last 12 months, Neurocrine had revenue of 2.86B and earned 478.60M in profits. Earnings per share was 4.81.
- Revenue
- 2.86B
- Gross Profit
- 2.81B
- Operating Income
- 619.10M
- Pretax Income
- 705.40M
- Net Income
- 478.60M
- EBITDA
- 666.60M
- Earnings Per Share (EPS)
- 4.81
Cash Flow
In the last 12 months, operating cash flow was 898.10M and capital expenditures -27.70M, giving a free cash flow of 870.40M billion.
- Operating Cash Flow
- 898.10M
- Free Cash Flow
- 870.40M
- Free Cash Flow per Share
- 8.62
Dividends & Yields
Neurocrine pays an annual dividend of $0.29, resulting in a dividend yield of ―
- Dividend Per Share
- $0.29
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 5.86%
- Earnings Yield
- 4.78%
Stock Price Statistics
- Beta
- 0.53
- 52-Week Price Change
- 6.65%
- 50-Day Moving Average
- 146.87
- 200-Day Moving Average
- 147.81
- Relative Strength Index (RSI)
- 57.33
- Average Volume (3m)
- 1,117
Important Dates
Neurocrine upcoming earnings date is Nov 02, 2026, After Close (Not Confirmed).
- Last Earnings Date
- Jul 30, 2026
- Next Earnings Date
- Nov 02, 2026
- Ex-Dividend Date
- Mar 15, 2022
Financial Position
Neurocrine as a current ratio of 3.39, with Debt / Equity ratio of 12.77%
- Current Ratio
- 3.39
- Quick Ratio
- 3.30
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -0.45
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Neurocrine has paid 226.80M in taxes.
- Income Tax
- 226.80M
- Effective Tax Rate
- 0.32
Enterprise Valuation
Neurocrine EV to EBITDA ratio is 16.25, with an EV/FCF ratio of 17.14.
- EV to Sales
- 4.42
- EV to EBITDA
- 16.25
- EV to Free Cash Flow
- 17.14
- EV to Operating Cash Flow
- 16.61
Balance Sheet
Neurocrine has $389.80M in cash and marketable securities with $401.80M in debt, giving a net cash position of -$12.00M billion.
- Cash & Marketable Securities
- $389.80M
- Total Debt
- $401.80M
- Net Cash
- -$12.00M
- Net Cash Per Share
- -$0.12
- Tangible Book Value Per Share
- $9.57
Margins
Gross margin is 97.97%, with operating margin of 23.38%, and net profit margin of 20.91%.
- Gross Margin
- 97.97%
- Operating Margin
- 23.38%
- Pretax Margin
- 27.87%
- Net Profit Margin
- 20.91%
- EBITDA Margin
- 27.21%
- EBIT Margin
- 25.81%
Analyst Forecast
The average price target for Neurocrine is $203.26, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- $203.26
- Price Target Upside
- 38.52% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 19
- Revenue Growth Forecast
- 34.42%
- EPS Growth Forecast
- 102.44%
Scores
- Smart Score
- 6
- AI Score
- ―